Alpha Teknova, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Stephen Gunstream, with a market cap of $167.7M.
Common questions about Alpha Teknova, Inc.
Alpha Teknova, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026 after market close. Analysts estimate revenue of $10.2M.
Alpha Teknova, Inc. has approximately 211 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.